The University Hospital Pitiè Salpêtrière – Charles Foix is part of the Assistance Publique–Hôpitaux de Paris – AP–HP Group (Great Paris University Hospitals, the Parisian public group of hospitals, the first and largest European hospital center) and the largest hospital in the entire AP–HP Group.
The University Hospital Pitiè Salpêtrière – Charles Foix is located in the very heart of the 13th arrondissement (district) of Paris and it includes, within 110 buildings on an average global 53 acres (Paris and Charles Foix), 77 healthcare services within the main 11 Medical Divisions specializing in the management and treatment of a wide spectrum of diseases, pathologies, and impairments in both children and adults.
The University Hospital Pitiè Salpêtrière – Charles Foix employs a total of over 8,970 medical professionals and specialists (1,559 physicians and specialists, 7,411 nurses and administrative staff) that work within its facilities to offer outstanding and comprehensive care to the population of Paris. Its physicians and specialized staff have continuously offered a high-quality care approach and have supported synergy between technical facilities, research units, and clinical-trial units. The University Hospital Pitiè Salpêtrière – Charles Foix has 2,189 hospital beds within the 11 specialized medical divisions (1,663 at the Pitiè Salpêtrière Hospital and 483 at the Charles Foix Hospital).
In 2014, the University Hospital Pitiè Salpêtrière – Charles Foix provided nearly 166,000 hospitalizations, 583,228 general and specialized consultations, and nearly 119,155 ER/ED (emergency room/emergency department) admissions.
In 2014, the hospitals treated and cared :
- 49,402 patients with all type of cancers ;
- 26,843 patients with neurological conditions;
- – 15,813 patients with cardio-vascular conditions;
- 12,635 patients with metabolic, endocrinological and nutritional pathologies;
- 11,192 patients with orthopedic and trauma conditions;
- 7,636 patients with digestive conditions;
- 4,413 patients in obstetrics;
- 3,278 patients with infections (SIDA, hepatitis…)
- The hospital operated 358 organ transplantations, of witch 18 were double joint transplantations.
The University Hospital Pitiè Salpêtrière – Charles Foix has at its disposal outstanding and cutting-edge technical and medical platforms providing to all patients excellences in diagnosis, treatment, and post-surgical follow-up:
- 15 Medical Laboratories
- 45 Operating Rooms
- 15 Radiology Rooms
- 78 beds in the ICU (Intensive Care Unit)
- 37 monitoring rooms
- 5 MRI (Magnetic Resonance Imaging)
- 3 new-generation diagnostic computers
- 1 Interventional Scanner
- 3 Gamma Cameras
- 1 PET scanner
- 1 lithotripter
- 1 Ablatherm Robotic H.I.F.U. (High-Intensity Focused Ultrasound)
- 2 Linear Accelerators for Radiotherapy Treatments
- 1 tomotherapy device
- 75 Ultrasound devices
- 1 Gamma Knife ®
- 1 Surgical Robot (Da Vinci Robot)
The University Hospital Pitié Salpêtrière – Charles Foix has, throughout the last two decades, received numerous awards and has been recognized for its excellence in patient care and healthcare services.
The HAS V2010 (Autorité de Santé (HAS) – or French National Authority for Health) certification has accredited the University Hospital Pitié Salpêtrière – Charles Foix without reserve.
- HAS V2010 certification (May 2014):
In the latest rankings of French Hospitals by the ‘Le Point’ magazine, the most important independent classification of Private and Public Health care institutions in France, Hôpital de la Pitié-Salpêtrière was ranked in the top 50 hospitals in the country. It was also ranked highly in the following areas on a national base:
Treatments for the cancers:
- Thyroid (1)
- Kidney (1)
- Stomach or esophagus (3)
- Liver or pancreas (3)
- ENT (10)
- Brain Tumour (10)
- Bone cancer surgery (10)
- Gynecological (11)
- Prostate (13)
- Colon (13)
- Bladder (19)
Bone and joint Surgery:
- Knee ligament (11)
Digestive surgery :
- Rectum surgery (21)
- Abdomen Hernia (22)
- Gall bladder (24)
- Artery surgery (6)
- Carotid surgery (7)
- High blood pressure (2)
- Miocardial infarction (4)
- Pacemaker (7)
- Cardiac Surgery (9)
Urology / Gynecology:
- Urinary incontinence (2)
- Urinary calculus (10)
- Prostate adenoma (14)
- Multiple sclerosis (1)
- Neuroma (1)
- Epilepsy (9)
- Pituirary surgery (13)
- Back surgery (17)
- Cerebral aneurysm (18)
- Stroke (20)
Head & neck:
- Trauma of the face (1)
- Hearing (7)
- Head trauma (8)
- Salivary gland (8)
- Infectious diseases (6)
Other medical specialities
- Hormonal disease (1)
- Viral hepatitis (5)
- Diabetes (13)
- Rheumatology (16)
source: the leading French weekly newsmagazine Le Point’s “2017 FRENCH BEST PRIVATE HOSPITALS” (Le Point’s hospital ranking is an established and influential one and presents an annual report of France’s hospitals and health care providers.)
Global healthcare services are provided to patients and their families through access to the two main sites: Pitiè Salpêtrière Hospital and Charles Foix Geriatric Hospital. The widest spectrum of pathologies, diseases, and treatments are addressed with comprehensive and expert care. It is organized as 11 main medical divisions of public health interest and healthcare offering:
- Surgery Division (386 beds)
- P.R.A.G.U.E.S. Division (Pneumology, Reanimation, Anesthesiology, Geriatric, Urgencies, Respiratory System Functional Exploration, and Sleep, 180 beds)
- M.S.N. Division (Nervous System Diseases and Pathologies, 414 beds)
- Neuro-sensory Surgery Division (141 beds)
- Cardio-metabolism Division (286 beds)
- Pathologies and Medical Biology Division
- 3I Division (Infections, Inflammation, and Immune System, 245 beds)
- Imaging Medical Division (4 beds)
- S.T.E.P.S. Division (Public Health and Health-Products Evaluation, 5 beds) • O.R.P.H.è. Division (Oncology, Radiotherapy, Palliative Care, and Hematology, 73 beds)
- Geriatric Medical Division (455 beds)
The Division of Surgery of the University Hospital Pitiè Salpêtrière – Charles Foix excels in treating patients with a vast array of abdominal, digestive, and endocrine disorders. The healthcare services offered include several departments and specialties: Cardiovascular Surgery, Orthopedic Surgery and Traumatology, General Endocrine, Gynecology, Urology, Nephrology, Kidney Transplantation, Gastrointestinal Surgery and Hepatobilio-Pancreatic Surgery, Dentistry, Stomatology and Maxillofacial Surgery.
Head of the Division: Pr. Fabrice MÉNÉGAUX
M.S.N. DIVISION (NERVOUS SYSTEM DISEASES AND PATHOLOGIES DIVISION)
The MSN division comprises all services involved in the management and treatment of neurological and psychiatric disorders, from the diagnostic phase to the active treatment phase, and, if necessary, the neurological ICU–Intensive Care Unit, to follow-up care and rehabilitation phases. Physicians at the MSN Division treat and offer comprehensive care to the following medical areas: Neurology, Psychiatry, Neurophysiology, Neurodegenerative Disorders, and Physical Medicine and Rehabilitation.
Head of the Division: Pr. Jean-Yves DELATTRE
The Cardio Metabolism Division offers a unique, personalized treatment plan for people with metabolic syndromes, heart disease, and reproductive system pathologies and diseases. Based on its successful cardiac rehabilitation program, the program combines medical treatments, surgeries, diet, and exercise prescriptions with a state-of-the-art facility, hands-on experience, and a focus on behavioral change in order to maximize success. The Cardiometabolism Division comprises several departments and operative units within the following areas: Cardiology, Cardiac and Thoracic Surgery, Intensive Care, Endocrinology, Metabolism, Diabetes, Nutrition, Reproductive Health, and General Medicine.
Head of the Division: Pr. Arnaud BASDEVANT
3I DIVISION (INFECTIONS, INFLAMMATION, AND IMMUNE SYSTEM)
The University Hospital Pitiè Salpêtrière – Charles Foix utilizes cohesive teams of physicians and surgeons who are recognized as experts in their respective specialties, making the “3I Division” a center of reference for rare diseases as well as tropical and gastrointestinal infections. Moreover, the “3I Division” comprises scientists and clinicians working together to promote and develop research, drug discoveries, and, ultimately, advances and improvements in patient care.
The Division is specialized and treats several pathologies and diseases within the following: Infectious and Tropical Diseases, Internal Medicine, Rheumatology, and Hepato-gastroenterology.
Head of the Division: Pr. Bruno FAUTREL
O.R.P.H.È. DIVISION (ONCOLOGY, RADIOTHERAPY, PALLIATIVE CARE, AND HEMATOLOGY)
The ORPHÈ Division at the University Hospital Pitiè Salpêtrière – Charles Foix combines clinical expertise, compassionate care, and advanced radiation therapies to deliver the safest, most effective treatments for cancer and benign tumors. Teams of experts and specialists provide precise targeting of tumors while minimizing the potential for injury to surrounding tissue. Moreover, the strong interconnections between the subspecialties of the ORPHÈ division allow the radiation oncology physicians to work closely with medical oncology and surgical oncology colleagues, and together they are able to develop an optimal treatment plan for each patient. The division includes the following subspecialties: Medical Oncology, Radiotherapy, Clinical Hematology, and Hemo-biotherapy.
Head of the Division: Pr. Véronique LEBLOND
The DHU (University-Hospital Department) groups several universities and Hospitals of the AP–HP, and it represents a dynamic driving force for creating new synergies and bringing innovative features to basic and clinical research.
To this end, all DHU universities and hospitals have a common goal – to create and enlarge all their clinical centers (health services, laboratories, functional units, etc.) and improve research quality and their facilities’ levels of excellence in order to make the DHU an international benchmark in the development of new therapies and the discovery of new treatments.
The Pitié Salpêtrière hospital is one of the most prolific and important medical research center in France.
In 2014, the medical teams got nearly 2,000 publications, 578 of them classified A for the significant impact on science and therapy.
The hospital hosted 309 industrial trials and 344 university medical trials.